Vantaa, Finland

Raimo Tuominen

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 6.1

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Helsinki, FI (2008)
  • Vantaa, FI (2014 - 2017)

Company Filing History:


Years Active: 2008-2017

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Raimo Tuominen: Innovator in Neurotrophic Factors

Introduction

Raimo Tuominen is a prominent inventor based in Vantaa, Finland. He has made significant contributions to the field of neurotrophic factors, particularly in the treatment of neuronal disorders. With a total of five patents to his name, Tuominen's work has the potential to impact the lives of many individuals suffering from various neurological conditions.

Latest Patents

Tuominen's latest patents include groundbreaking inventions such as the neurotrophic factor MANF and its uses. This invention focuses on the treatment of neuronal disorders, providing a pharmaceutical compound that comprises MANF nucleic acid molecules, MANF proteins, or functional fragments for treating peripheral neuropathies, including Alzheimer's disease, Parkinson's disease, epilepsy, drug addiction, and ischemic brain injury. Another notable patent is for MANF2, a novel neurotrophic factor protein that offers a genetic sequence encoding the same. This molecule is expected to be useful in developing therapeutics and diagnostics for MANF2 dependent conditions, particularly affecting dopaminergic neurons in the central nervous system.

Career Highlights

Throughout his career, Tuominen has worked with various companies, including Herantis Pharma Plc and Licentia Ltd. His expertise in neurobiology and innovative approaches to treatment have positioned him as a key figure in the field. His contributions have not only advanced scientific understanding but also opened new avenues for therapeutic interventions.

Collaborations

Tuominen has collaborated with notable colleagues such as Mart Saarma and Juha Lauren. These partnerships have fostered a collaborative environment that enhances research and development in neurotrophic factors.

Conclusion

Raimo Tuominen's work in neurotrophic factors represents a significant advancement in the treatment of neuronal disorders. His innovative patents and collaborations highlight his commitment to improving therapeutic options for patients. The impact of his inventions is likely to resonate within the scientific community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…